WO2003057052A1 - Appareil d'injection microdosée d'un produit actif par des jets de liquide de travail sous pression et procédé de génération d'une séquence de jets liquides au moyen de cet appareil. - Google Patents
Appareil d'injection microdosée d'un produit actif par des jets de liquide de travail sous pression et procédé de génération d'une séquence de jets liquides au moyen de cet appareil. Download PDFInfo
- Publication number
- WO2003057052A1 WO2003057052A1 PCT/FR2003/000026 FR0300026W WO03057052A1 WO 2003057052 A1 WO2003057052 A1 WO 2003057052A1 FR 0300026 W FR0300026 W FR 0300026W WO 03057052 A1 WO03057052 A1 WO 03057052A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- liquid
- active product
- working liquid
- branch
- active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B17/3203—Fluid jet cutting instruments
- A61B17/32037—Fluid jet cutting instruments for removing obstructions from inner organs or blood vessels, e.g. for atherectomy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00234—Surgical instruments, devices or methods for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00392—Transmyocardial revascularisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M2005/14513—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons with secondary fluid driving or regulating the infusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16804—Flow controllers
- A61M5/16827—Flow controllers controlling delivery of multiple fluids, e.g. sequencing, mixing or via separate flow-paths
Definitions
- the present invention relates to a surgical, medical or diagnostic apparatus with jets of pressurized liquid making it possible to carry out one or more microdose injections of an active or treatment product. It also relates to an injection process using this device.
- an active product for example a drug, a product useful for surgical intervention or a diagnostic agent, directly in contact with the sick or to be treated area which is most often located inside the human body, in an organ or in the tissue thereof.
- an injection catheter is used for this, which is inserted and pushed along a vessel inside the patient's body until its distal end, having a or several orifices or possibly extended by an injection needle, is as close as possible to the area to be treated. Then the active product is injected under pressure onto the area to be treated through the opening (s) or the needle at the end of the injection catheter.
- the object of the invention is to provide an apparatus and a method making it possible to improve the injection, in particular of this type of product.
- needleless devices for injecting a treatment product under pressure. With this type of device, there is no longer any mechanical perforation of the tissue prior to injection. Penetration into the tissue is effected by the pressure force of the liquid which, after being ejected, strikes the tissue with sufficient force to perforate it and form an injection channel, then diffuses into the tissue from this channel . Thanks to the pressure with which it is injected, the treatment liquid penetrates a lot deeper than with a conventional needle injection device and its distribution is more extensive.
- These devices can be equipped with a catheter which makes it possible to inject inside the patient's body, directly in contact with the organ or tissue to be treated.
- these pressure injection devices have many advantages compared to conventional devices, they are not suitable for the injection of active products used in the context of gene or cell therapies. Indeed, these products, often containing viruses or living cells, are very fragile. When they are ejected under pressure by this type of device, they deteriorate through the violence of the shock against the treated tissue which generally causes the death of living cells and destroys the entire activity potential of the product.
- the object of the invention is to teach a pressure injection device, having all the advantages of this type of device, but making it possible to inject a fragile active product, such as for example a transgenic product, without any deterioration.
- the inventive principle consists in dissociating the phase of producing an injection channel, harmful for fragile substances, from that of injecting the active product.
- the device according to the invention makes it possible to make a shot of a working liquid under pressure against the tissue to be treated so as to hollow out an injection channel, then to inject the active product into this channel.
- the active product not being used to dig the conduit, does not undergo a violent shock and is perfectly preserved. It can however be sent under pressure and deep into the targeted tissue. Its diffusion is therefore greatly improved compared to a conventional injection device.
- This device provides either for direct mixing of the treatment product in the reserve of working liquid, or for having a reserve of working liquid and an independent reserve of treatment product, both being pressurized by a generator. pressure.
- the active product is diluted in the working liquid and is used at the same time as this.
- Such a scenario cannot be suitable for the fragile products targeted by the invention. Indeed, they would then be destroyed by digging the injection channel.
- the working liquid most often physiological saline, is generally packaged in flexible plastic bags of large capacity, conventionally one liter.
- the active product expensive and difficult to manufacture, is generally in the form of small quantities and would be very strongly diluted in the reserve of working liquid, which would lead to a concentration in the injected form incompatible with the desired applications.
- a reserve of treatment product is pressurized by the pressurized liquid generator.
- the surgeon triggers the firing of the active product by means of a switching or mixing device which is not described.
- Application WO 00/56232 also generally envisages the production of combinations of pulses of working liquid and of treatment product within a discontinuous train of pulses constituting a pulsed jet, using a multiplexing means not described. These different variants are envisaged in a very general way, without a precise embodiment being described and therefore remain on a purely theoretical level.
- the invention makes it possible to provide a concrete embodiment of this general principle by teaching a bypass device playing the role of this mixing, switching or multiplexing member.
- the injection device comprises, like the device described in this previous application, a reserve of working liquid which can be pressurized by a pressurized liquid generator, a handpiece ending in one end.
- active comprising means for outputting a jet of pressure, continuous or pulsed, working liquid and a jet of active product.
- the apparatus further comprises: - a main branch of the fluid circuit, connecting the reserve of working liquid to the handpiece, and in which the flow is controlled by the state of a first valve;
- a secondary branch branch parallel to the main branch and fluidly isolated from the latter, intended to contain the active product, and in which the flow is controlled by the state of a second valve;
- a multiplexing means making it possible to independently control the opening and closing of the valves of each of the two branches of the circuit according to predetermined parameters.
- the invention thus teaches for example a method of generating a sequence of liquid jets by means of a similar device in which the two valves of the two branches of the circuit are simultaneously opened in order to produce this mixture in the active end of the 'apparatus and generate a jet consisting of a mixture of active product and working liquid whose proportions are precisely fixed by adjusting the opening time of each valve.
- the invention also teaches an injection method using this device in which an injection channel is dug by firing a jet of working liquid under pressure, then in a subsequent phase, the active product is injected into this channel injection.
- the injection channel being hollowed out firstly by firing the jet of pressurized working liquid, the active product injected in a second time is perfectly preserved.
- a process for generating a sequence of liquid jets by means of an apparatus comprising a reserve of working liquid pressurized by a pressurized liquid generator, a handpiece ending in an active end.
- which comprises means for outputting a pressurized jet of working liquid and a jet of an active product, a main branch of the fluid circuit, connecting the reserve of working liquid to the handpiece, in which the flow is controlled by the open or closed state of an isolation valve, a secondary branch branch, parallel to the main branch and fluidly isolated from the latter, intended to contain an active product and in which the flow is controlled by the open or closed state of an isolation valve, and a multiplexing means for independently controlling the opening and closing of the isolation valves according to parameters. very predetermined.
- This process is characterized in that one generates a sequence comprising at least one pulse of working liquid under pressure, followed by a microdosed pulse of active product.
- the valve of the main branch of the circuit is first opened in order to generate a pulse formed of an appropriate quantity of working liquid under pressure, then in a next step the valve of the branch branch is opened in order to generate a pulse formed by the desired amount of active product.
- the quantities of liquid forming the pulses of working liquid and of active product can be precisely established by fixing the opening times of each of the valves.
- the active product pulse can possibly be followed by a new pulse of pressurized working liquid.
- This new impulse can for example serve to push the active product deeper into the heart of the tissue to be treated.
- the pulse of active product can also be generated under high pressure, that is to say with a pressure corresponding substantially to that of the working liquid.
- the pulse of active product can also be generated at a pressure lower than that of the working liquid and preferably at low pressure.
- the apparatus and the method according to the invention make it possible to easily use very small quantities of active product and to carry out microdoses thereof.
- the apparatus and method according to the invention are therefore particularly well suited for the injection of transgenic active products. They can however be used in all kinds of other surgical, medical, therapeutic or diagnostic applications, as well as in applications relating to different technical fields.
- FIG. 1 is a general schematic view of the injection apparatus according to the invention
- FIG. 2 is a schematic view of a part of the injection apparatus according to the invention corresponding to the main branch and to the branch of the hydraulic circuit;
- Figure 3 is a schematic view similar to that of Figure 2, showing the part of the injection device according to the invention corresponding to the main branch and the branch branch of the circuit, with a small diameter conduit;
- FIG. 4 is a view of another variant of the part of the injection device according to the invention corresponding to the main branch and to the branch branch of the circuit, not comprising a valve for introducing the active product but in which the bypass tubing serves as a metered reserve of active product; .
- FIG. 5 is a graph representing the nature and the quantity of liquid delivered by the apparatus over time, during a particular example of its application to two successive microdose injections of active product.
- FIGS. 6 to 12 are schematic views of a part of the injection device according to the invention, corresponding to the main branch and to the branch branch of the circuit and to the catheter, in various configurations corresponding to different times, referenced from
- FIG 1 there is shown schematically an injection device 1 according to the invention capable of sending one or more jets of sterile working liquid under pressure and inject one or more microdose quantities of active product.
- This device comprises a reserve 2 of working liquid, for example a flexible plastic bag containing the working liquid, connected to a generator 3 of pressurized liquid.
- the generator 3 of pressurized liquid is an enclosure in which the reserve 2 of working liquid is enclosed and which is filled with a neutral gas under pressure in order to compress the bag and put the liquid under pressure.
- the pressure of the jet of liquid generated can be adjustable in order to adapt it to the needs.
- the pressure inside the enclosure is preferably between 0.3 and 200 bars and preferably between 0.3 and 100 bars.
- the enclosure can also be thermostatically heated to a temperature close to or slightly above 37 ° C so that the working liquid reaching the intervention site is approximately the same temperature as the patient's body.
- the working liquid used is preferably sterile physiological serum used at an appropriate pressure depending on the application.
- a suitable high pressure value of the working liquid cited here only by way of example is around 20 bars.
- sterile liquids can obviously be used as sterile working fluid such as for example a saline solution, a solution of glucose, of Ringer-lactate, of hydroxyethyl starch or a mixture of these solutions.
- the sterile working liquid is supplied by through a tube forming the main branch 4 of the hydraulic circuit, to a handpiece 5 which allows the user to control the triggering of the jet of working liquid and / or active product and to direct it.
- the handpiece 5 has an ergonomic body 6, allowing easy gripping and handling and may have control members such as for example push buttons 7.
- the handpiece 5 is extended by an active end 8. It s 'Acts in this variant of a catheter 9. It is conventionally in the form of a flexible conduit 10 in and along which passes the sterile working liquid under pressure as well as the active or treatment product.
- the catheter 9 includes a proximal end 11 manipulated by the surgeon and a distal end 12 inserted inside the patient's body.
- the distal end 12 of the catheter has one or more orifices through which the working liquid and the active product are ejected.
- the catheter 9 may include known navigation and orientation means which, not forming part of the invention, have not been shown in the figures. Its distal end 12 is articulated and may further include a locating system in order to be able to position itself at the appropriate place and at a preferential inclination, the assembly being controlled from the handpiece 5.
- the catheter 9 may also include an anchoring system in order to ensure immobilization of the active distal end during fluid shots, thereby improving the precision of the interventions. It can be any mechanical anchoring means or a means using suction.
- the injection device 1 comprises a suction system 13 connected to a vacuum source 14, for example a vacuum pump or the general vacuum circuit of the hospital. These optional means have been shown in broken lines in FIG. 1.
- catheter 9 which comprises a suction conduit surrounding the conduit 10 concentrically and flaring at the distal end 12 of the catheter to form a skirt.
- the surgeon can press the distal end against this zone by triggering the suction at the level of the skirt which then behaves like a suction cup.
- the skirt physically isolates the injection site from the blood circulation and from the rest of the patient's body.
- the active product useful and beneficial on the targeted area, can be harmful, even toxic if it is applied to other organs of the patient not concerned by the treatment.
- gene therapies during which it is possible, for example, to administer to the target organ genes, cells, nucleic acids or genetically modified proteins, applied in isolation or by means of a vector for example a virus.
- the administered product developed for a specific application, remains localized at the site of its injection and is not carried away from the treatment site by the flow of the blood circulation in order to avoid it ending up inadvertently. other non-target organs.
- the active product is injected deep into the heart of the tissue to be treated, which greatly reduces the probability that it will come out of the injection channel and lead to an organ not concerned by the treatment.
- the injection site is completely isolated from the patient's blood circulation, until a complete diffusion of the active product in the tissue concerned has occurred. The risks of accidental dispersion are thus further reduced.
- these active ingredients are often formulated in the form of a particularly viscous liquid in order to prevent it from flowing out of the injection channel.
- the device according to the invention is perfectly suited for injecting products whatever their viscosity.
- the catheter 9 may comprise at its distal end a retractable puncturing or pricking tool, preferably of the retractable needle type, movable between a working exit position and a retracted safety position inside the catheter, allowing to perform a puncture work initiating the digging of the injection channel by a mechanical perforation.
- the exit of the end tool can be caused automatically by the pressure of the liquid escaping from the catheter, the end tool being automatically retracted inside the catheter in the absence liquid or if its pressure is below a threshold value.
- the injection device 1 also includes a secondary branch branch 15 intended to contain the active product to be injected.
- This secondary tubing 15 is preferably connected to a reserve of active product or of treatment 16 by means of communication 17.
- the reserve of active product 16 can be of any kind. It is for example a self-piercing system of a precise dose of active product. It can also be a simple syringe in which the surgeon has placed the active product and which he uses to introduce the active product into the injection device via the communication means 17.
- the communication means 17 can for example be a three-way charge valve 18 as shown in the figures.
- the charging valve 18 is preferably a two-way valve.
- the surgeon can initially put the reserve of active product 16 in communication with the secondary branch 15 of the device in order to load the latter with active product.
- the charging valve is then placed in the configuration shown in FIG. 3.
- the surgeon can thus, for example, fill the secondary tubing 15 with the contents of a syringe.
- it can put the secondary branch branch 15 in communication with the main branch 4, the device then being ready for injection.
- the tap is in the configuration of Figures 1 and 2.
- the secondary branch branch 15 is isolated from the main branch 4 of the fluid circuit by two non-return valves 19 and 20 positioned at the two ends of the branch manifold, respectively at the inlet and at the outlet thereof.
- a non-return valve 21 is preferably disposed at the outlet of the main pipe 4 so as to avoid any return of working liquid or active product which may cause contamination upstream of the fluid circuit.
- the fluid circulation in each of the branches of the circuit depends on the open or closed state of two isolation valves 22 and 23 respectively equipping the main branch and the secondary branch of the circuit.
- At least one of these isolation valves 22 or 23, and preferably both, comprises or each comprise, a roller with a cam profile which in the closed position crushes the tubing from the outside .
- the two isolation valves 22 and 23 are mounted in the immediate vicinity of the non-return valves 20 and 21. If the technical or technological possibilities allow it, the non-return valves 20 and 21 are or will be integrated into the isolation valves 22 and 23 or vice versa.
- these two valves are controlled, preferably electronically, by a multiplexing means 24.
- these two isolation valves 22 and 23 are actuated independently of one of the 'other.
- the multiplexer 24 controls the opening and closing of the isolation valves 22 and 23 in function of time and duration parameters, previously recorded by the surgeon and which may be any, in order to achieve an optimal injection sequence for the particular case to be treated.
- This firing of working liquid under pressure can for example make it possible to dig an injection channel. It can also be used for any other appropriate cutting or dissection application, before or after the injection.
- the working fluid under pressure can be fired according to a practice known in this field.
- the isolation valve 22 When the isolation valve 22 is closed and the isolation valve 23 open, the pressurized working liquid circulates in the branch branch 15 and pushes the active product present in the secondary branch. In this way, the active product is propelled by the working liquid under pressure to the distal end of the catheter and is injected into the previously dug injection line.
- the two isolation valves are open simultaneously, a mixture is formed at the union of the two branches of the circuit and a diluted active product is ejected from the catheter.
- the surgeon can obtain numerous injection possibilities by varying the opening and closing parameters of the isolation valves 22 and 23.
- the injection device ensures the perfect sterility required for surgical type interventions. Indeed, all the elements of the fluidic circuit, likely to be contaminated, are disposable sterile elements and for single use: from the sterile bag containing the working liquid, to the reserve of active product, to the various pipes, valves, valves , fittings and other hydraulic components, up to the handpiece and catheter.
- FIG. 1 all the disposable elements of the injection device intended for single use have been shown in gray. The elements intended to be kept have been shown in black.
- Figure 4 shows in more detail another embodiment of the invention.
- the main 4 and secondary 15 branches of the circuit are arranged in parallel and connected at their ends by the bifurcations 25 and 26.
- the main branch 4 decomposes respectively, from the bifurcation 25 and in the direction of flow of the fluid, into a tube 27 which can be crushed, preferably at its end, by the cam of the isolation valve 22, a non-return valve 21 and a tube 28 leading to the bifurcation 26.
- the secondary branch 15 decomposes respectively, from the bifurcation 25 and in the direction of flow of the fluid, into a tube 29, a non-return valve 19, a tube 30 which can be crushed, preferably at its end, by the cam of the isolation valve 23, a non-return valve 20 and a tube 31 leading to the bifurcation 26.
- a tube 32 common to the two branches will supply the handpiece 5.
- the injection device may not include any active liquid charging valve.
- the tubing 30 directly plays the role of the reserve of active product 16.
- the portion of tubing 30 serves as a calibrated reserve for a precise dose of active product.
- the device according to the invention allows injections of micro-amounts of active product to be carried out in a simple and effective manner according to a precise dosage.
- an internal diameter suitable for the pipes is for example close to 1.5 mm. In order to reduce the volume of the reserve of active product while ensuring its good conservation, it is then possible to reduce the length of the calibrated tubing 30.
- Tubing, non-return valves, valves and other elements of the fluid circuit are made of materials resistant to high pressure. It is thus possible, for example, to use high-pressure tubing made of braided polyamide.
- Certain active products are moreover sensitive to high pressure and cannot be injected under a pressure identical to that of the working liquid without risking deterioration detrimental to their effectiveness.
- the secondary branch branch 15 may comprise a portion of tubing 33 of reduced internal diameter, serving to greatly reduce the pressure of the liquid passing through it .
- This portion of tubing 33 of reduced internal diameter preferably replaces the portion of tubing 29, located at the inlet of the secondary branch branch 15 before the non-return valve 19.
- the isolation valve 23 is open, the liquid of working under pressure, coming from the reserve 2 and the generator of liquid under pressure 3, enters the portion of tubing or restriction 33 having a greatly reduced diameter. This constriction causes a significant decrease in its pressure before it comes into contact with the active product. present in the tubing 30 of the branch branch.
- the active product can thus be ejected with a pressure much lower than that of the working liquid, which advantageously preserves the most fragile substances.
- This pressure reduction can be modulated by varying the diameter and the length of the restriction 33.
- the tubing or restriction 33 has for example an internal diameter close to 0.3 mm.
- the working liquid is the only one to pass through the portion of tubing 33, it is possible to greatly reduce its diameter without risking damaging the living cells of the active product.
- the injection device advantageously makes it possible to produce an injection channel under high pressure and then to inject an active product at low pressure.
- the opening time of the isolation valve 23 cannot be reduced below a minimum duration limit imposed by the characteristics of the device. This minimum opening time causes the injection of a minimum quantity of active product which cannot be reduced for the same injection pressure.
- the apparatus according to the invention thus advantageously allows injections of microquantities of active product.
- the injection device used comprises a catheter containing a volume of 600 ⁇ l and a calibrated bypass tube of 500 ⁇ l.
- the surgeon first purges the injection device in order to expel the air it contains to fill it with working liquid. To do this, it opens the isolation valves 22 and 23 and triggers the flow of the working liquid.
- the charging valve 18 must be placed in the configuration of FIGS. 1 and 2, putting the secondary branch 15 into communication with the main branch 4.
- the working liquid gradually fills the main branch 4, the bypass branch 15 and the catheter 9.
- the surgeon closes the isolation valves 22 and 23.
- the flow of working liquid at the outlet of the catheter stops.
- the entire internal hydraulic circuit of the injection device is filled with working liquid. The device is then in the configuration shown in FIG. 6.
- the surgeon then performs the loading of the device with active product. For this, it opens the charging valve 18, as in FIG. 3, so as to put the bypass line 15 into communication with the reserve of active product 16. It can be, for example, a syringe filled with product. active which it places at the inlet of valve 18.
- the shots are then prepared by successively arranging the fluid packets in an appropriate order and quantities and placing them in the firing position at the end of the catheter just before the outlet.
- the isolation valve 23 is open at time t 5 for a period corresponding to a flow through this valve of 160 ⁇ l of active product pushed by the entry of 160 ⁇ l of working liquid under pressure into the branch of bypass 15.
- the isolation valve 23 is closed and the isolation valve 22 is open until time t 7 .
- This opening time corresponds to the flow of 140 ⁇ l of working liquid under pressure through the valve 22. 140 ⁇ l of working liquid are expelled simultaneously from the catheter.
- the apparatus is then in the situation of FIG. 9.
- the isolation valve 22 is closed and the isolation valve 23 is open until time t 8 .
- This opening time corresponds to the flow of 160 ⁇ l of active product through the valve 23, pushed by the working liquid under pressure. 160 ⁇ l of working liquid are expelled simultaneously from the catheter.
- the two isolation valves are closed so as to stop the flow.
- the device is then in the situation in FIG. 10. It is ready to carry out the injections.
- the surgeon places the active distal end of the catheter, in the firing position, in contact with the wall area of the organ or tissue to be treated.
- the isolation valve 22 is open from t 9 to t 10 , which corresponds to the duration of ejection of the first shot at the distal end of the catheter.
- This shot is composed a first pulse of 140 ⁇ l of pressurized working liquid used to dig the injection channel, followed by a second pulse of 160 ⁇ l of active product injected in a second time into this channel.
- the two valves are closed.
- the device is then in the situation in FIG. 11.
- the surgeon can move the active end of the catheter to a second firing position.
- it triggers the second shot.
- the valve 22 is open from t n to t 12 , corresponding to the time necessary for the ejection of the second shot at the distal end of the catheter.
- This shot is, like the previous one, composed of a first pulse of 140 ⁇ l of pressurized working liquid used to dig the injection channel, followed by a second pulse of 160 ⁇ l of active product injected in a second step in this channel.
- the two shots can possibly be carried out successively in the same place.
- the time interval t 10 -t n during which the two isolation valves are closed becomes superfluous and can be eliminated, the two shots then succeeding each other without interruption.
- the opening times of the isolation valves 22 and 23 are modified as a function of the viscosity of the liquids used.
- the method for generating a sequence of liquid jets can comprise the following steps: - purging the device in order to expel the air it contains to fill it with working liquid; - loading the device with active product;
- the apparatus according to the invention may be suitable in the context of a wide variety of medical, surgical or diagnostic interventions on all the organs of the body of a living being or in ex situ surgery.
- the surgical device according to the invention is for example particularly suitable for performing interventions such as transmyocardial or myocardial revascularization, because it allows the realization of revascularization ducts in the ischemic zone of the myocardium then the injection into these ducts of angiogenic substances for example of the growth factor type.
- the device according to the invention makes it possible to inject the most diverse substances such as for example therapeutic products, products having an action linked to the intervention in progress or diagnostic, contrast products.
- therapeutic products such as for example therapeutic products, products having an action linked to the intervention in progress or diagnostic, contrast products.
- contrast products can be conventional chemical molecules or products from biotechnology and genetic engineering.
- the invention is obviously not limited to an apparatus which can inject only one active product. It is possible to imagine, in accordance with the principle of the invention, an injection device comprising several branch branches, arranged in series or in parallel, and allowing the application of various active products, mixed or successively according to previously programmed characteristics.
- the apparatus and method previously described are not limited to applications in the surgical, medical or diagnostic field.
- the method for generating a sequence of liquid jets according to the invention is a general method which can find application in many other fields such as, for example, construction, agriculture, food industry, chemical laboratories or biology, engraving and drawing, tattooing, cleaning or other.
- - in the building sector for example for the treatment of wood, the injection of hardening, treating or drying products in walls and walls;
- - in the laboratory for the microdose injection of reagents inside basic products intended for example to be analyzed or to be used for the preparation of vaccines or drugs;
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/500,990 US20050090778A1 (en) | 2002-01-07 | 2003-01-07 | Apparatus for the microscopically-dosed injection of an active product by means of jets of pressurized working liquid and the method of generating a sequence of liquid jets using said apparatus |
EP03712215A EP1460948A1 (fr) | 2002-01-07 | 2003-01-07 | Appareil d'injection microdosee d'un produit actif et procede |
AU2003216790A AU2003216790A1 (en) | 2002-01-07 | 2003-01-07 | Apparatus for the microscopically-dosed injection of an active product by means of jets of pressurised working liquid and the method of generating a sequence of liquid jets using said apparatus |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0200129A FR2834442B1 (fr) | 2002-01-07 | 2002-01-07 | Appareil d'injection microdosee d'un produit actif par des jets de liquide de travail sous pression et procede de generation d'une sequence de jets liquides au moyen de cet appareil |
FR02/00129 | 2002-01-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003057052A1 true WO2003057052A1 (fr) | 2003-07-17 |
Family
ID=8871183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2003/000026 WO2003057052A1 (fr) | 2002-01-07 | 2003-01-07 | Appareil d'injection microdosée d'un produit actif par des jets de liquide de travail sous pression et procédé de génération d'une séquence de jets liquides au moyen de cet appareil. |
Country Status (5)
Country | Link |
---|---|
US (1) | US20050090778A1 (fr) |
EP (1) | EP1460948A1 (fr) |
AU (1) | AU2003216790A1 (fr) |
FR (1) | FR2834442B1 (fr) |
WO (1) | WO2003057052A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060111695A1 (en) * | 2004-11-24 | 2006-05-25 | Albert Geisser | Medical device for generating a jet composed of a gas and a liquid |
IL168616A (en) * | 2005-05-16 | 2010-12-30 | Michael Tavger | High velocity liquid-gas stream device for administering therapeutic substances |
FR3015298B1 (fr) * | 2013-12-23 | 2016-02-05 | Nestis | Ensemble hydraulique de generateur de jets pulses ou non pulses moyenne et haute pression |
CN109010991B (zh) * | 2018-08-29 | 2023-05-26 | 四川大学华西医院 | 输液器与取样方法和冲管方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4558989A (en) * | 1979-05-04 | 1985-12-17 | Wellcome Australia Limited | Fluid pump |
WO1993012825A1 (fr) * | 1991-12-20 | 1993-07-08 | Abbott Laboratories | Systeme d'administration automatique de medicaments par auto-amorçage |
WO2000056232A1 (fr) | 1999-03-22 | 2000-09-28 | Saphir Medical Products Gmbh | Appareil pour la dissection par liquide sous pression et l'injection par projection sous pression d'un produit de traitement |
WO2001041656A1 (fr) * | 1999-12-08 | 2001-06-14 | Boston Scientific Limited | Procede et dispositif d'injection sans aiguille |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51130094A (en) * | 1975-05-08 | 1976-11-12 | Asahi Chemical Ind | Twoostage pressure injector |
US4101981A (en) * | 1977-04-15 | 1978-07-25 | Boden Ogden W | Ventilated hat or cap |
US4559036A (en) * | 1983-12-14 | 1985-12-17 | Wunsch Richard E | Apparatus for controlling administration of multiple intravenous solutions and medications |
US4857056A (en) * | 1988-07-06 | 1989-08-15 | Sherwood Medical Company | Auto-flush syringe pump |
US5188603A (en) * | 1991-01-03 | 1993-02-23 | Vaillancourt Vincent L | Fluid infusion delivery system |
US5116316A (en) * | 1991-02-25 | 1992-05-26 | Baxter International Inc. | Automatic in-line reconstitution system |
US5569181A (en) * | 1993-10-28 | 1996-10-29 | Medrad, Inc. | Sterility assurance for contrast delivery system |
AU2260397A (en) * | 1996-01-31 | 1997-08-22 | Trustees Of The University Of Pennsylvania, The | Remote control drug delivery device |
US5807312A (en) * | 1997-05-23 | 1998-09-15 | Dzwonkiewicz; Mark R. | Bolus pump apparatus |
US6122773A (en) * | 1999-04-15 | 2000-09-26 | Katz; Marc | Ventilated hardhat |
US6598236B1 (en) * | 1999-10-25 | 2003-07-29 | Tracy R. Gantt | Headgear cooling and protective air flow system |
US6652483B2 (en) * | 2000-11-07 | 2003-11-25 | Avant Drug Delivery Systems, Inc. | Needleless jet injector system with separate drug reservoir |
US6692466B1 (en) * | 2000-12-21 | 2004-02-17 | Advanced Cardiovascular Systems, Inc. | Drug delivery catheter with retractable needle |
US6582393B2 (en) * | 2001-05-29 | 2003-06-24 | Therafuse, Inc. | Compensating drug delivery system |
WO2002098493A1 (fr) * | 2001-06-01 | 2002-12-12 | I-Flow Corporation | Procede et dispositif pour bolus de large volume |
US6760925B1 (en) * | 2002-12-31 | 2004-07-13 | Milton L. Maxwell | Air-conditioned hardhat |
-
2002
- 2002-01-07 FR FR0200129A patent/FR2834442B1/fr not_active Expired - Fee Related
-
2003
- 2003-01-07 AU AU2003216790A patent/AU2003216790A1/en not_active Abandoned
- 2003-01-07 EP EP03712215A patent/EP1460948A1/fr not_active Withdrawn
- 2003-01-07 WO PCT/FR2003/000026 patent/WO2003057052A1/fr not_active Application Discontinuation
- 2003-01-07 US US10/500,990 patent/US20050090778A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4558989A (en) * | 1979-05-04 | 1985-12-17 | Wellcome Australia Limited | Fluid pump |
WO1993012825A1 (fr) * | 1991-12-20 | 1993-07-08 | Abbott Laboratories | Systeme d'administration automatique de medicaments par auto-amorçage |
WO2000056232A1 (fr) | 1999-03-22 | 2000-09-28 | Saphir Medical Products Gmbh | Appareil pour la dissection par liquide sous pression et l'injection par projection sous pression d'un produit de traitement |
WO2001041656A1 (fr) * | 1999-12-08 | 2001-06-14 | Boston Scientific Limited | Procede et dispositif d'injection sans aiguille |
Also Published As
Publication number | Publication date |
---|---|
FR2834442B1 (fr) | 2004-10-08 |
FR2834442A1 (fr) | 2003-07-11 |
EP1460948A1 (fr) | 2004-09-29 |
AU2003216790A1 (en) | 2003-07-24 |
US20050090778A1 (en) | 2005-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2830455A1 (fr) | Catheter a outil d'extremite perforant ou piquant retractable | |
US11027066B2 (en) | Three-chambered autoinjector | |
EP1131124B1 (fr) | Dispositif destine a assurer la delivrance d'une substance active directement au sein d'un tissu cellulaire, moyen d'implantation du dispositif et appareils destines a l'injection de substance active dans ledit dispositif | |
US7458956B1 (en) | Apparatus for delivery of controlled doses of therapeutic drugs in endoluminal procedures | |
CA2344214C (fr) | Seringues pour l'administration de formulations pateuses ou semi-solides | |
JP3260375B2 (ja) | 粒子投入 | |
EP1441781A1 (fr) | Appareil de liposuccion | |
KR20230048440A (ko) | 주입 카테터 및 사용 방법 | |
EP0564321A2 (fr) | Dispositif d'injection d'un médicament | |
EP1460948A1 (fr) | Appareil d'injection microdosee d'un produit actif et procede | |
JP7449130B2 (ja) | 器具、器具ヘッドおよび施与システム | |
KR101960133B1 (ko) | 기구 헤드, 기구 헤드를 가지는 투약 기구, 투약 시스템, 및 공급 시스템을 동작시키는 방법 | |
FR2775603A1 (fr) | Dispositif d'injection sous cutanee sans aiguille a pulverisation | |
JP6999560B2 (ja) | フォームを分配する装置および方法 | |
EP1164947B1 (fr) | Appareil chirurgical a jet de liquide sous pression pour la revascularisation transmyocardiale | |
WO2014113576A9 (fr) | Dispositif d'injection sans aiguille et procédés d'administration d'une ou de plusieurs injection(s) sans aiguille à un organe d'intérêt | |
WO2024199954A1 (fr) | Dispositif portable pour la détection d'une obstruction, le suivi de l'obstruction et la désobstruction d'un cathéter | |
WO2007112520A2 (fr) | Dispositif de perfusion veineuse implantable | |
FR3124397A1 (fr) | Dispositif destiné à la thérapie par injection de fluide | |
FR2881052A1 (fr) | Dispositif de stockage et de melange de deux substances, procede de fabrication et applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003712215 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10500990 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2003712215 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |